CVS Health

CVS Health
Formerly called
Melville Corporation
(1922-1996)
CVS Corporation
(1996-2007)
CVS Caremark Corporation
(2007-2014)
Public
Traded as NYSE: CVS
Industry Health Care
Founded
Headquarters Woonsocket, Rhode Island, United States
Area served
United States
Key people
Revenue Increase US$139.36 billion (2014)[1]
Increase US$8.278 billion (2014)[1]
Increase US$4.644 billion (2014)[1]
Total assets Increase US$74.18 billion (2014)[1]
Total equity Increase US$37.95 billion (2014)[1]
Number of employees
137,800 (2015)[1]
Subsidiaries
Slogan Health is everything
Website cvshealth.com

CVS Health (formerly CVS Caremark Corporation[2]) is an American retailer and health care company. CVS Health operates over 7,800 CVS Pharmacy, Longs Drugs and Navarro Discount Pharmacies stores;[3] a pharmacy benefit manager, mail order and specialty pharmacies, a retail-based health clinic subsidiary, MinuteClinic; and an online pharmacy, CVS.com. CVS Health is chartered in Delaware, and is headquartered in Woonsocket, Rhode Island, where its four business units are also headquartered. As of 2014, it ranked 35th in the Fortune Global 500 list of the world's largest companies, and 10th in the United States-only Fortune 500.[4][5][6]

Background

CVS Health has four operating segments: CVS/pharmacy, CVS/caremark, CVS/specialty and CVS/minuteclinic which operates within CVS/pharmacy stores.

History

According to the International Directory of Company Histories,[7]

"Later in 1999 CVS acquired Soma.com, the first major online pharmacy, for $30 million in stock. The web site, soon rebranded CVS.com, enabled customers to order prescriptions and general merchandise for either in-store pickup or mail delivery. Another initiative in 1999 was the launching of CVS ProCare, a chain of specialty pharmacies, about 1,500 square feet in size, serving patients with chronic diseases and conditions that require complex and expensive drug regimens. The market for specialty pharmaceuticals, estimated at about $16 billion in 1999, was a particularly fast-growing segment of the drug industry, but it was highly fragmented, consisting mostly of mom-and-pop operations. CVS clearly saw the potential for being a consolidator in this segment of the market. Its first such acquisition came in September 2000 with the purchase of Stadtlander Pharmacy, a Pittsburgh-based subsidiary of Bergen Brunswig Corporation, for $124 million. Stadtlander generated annual revenues of $500 million by selling drugs by mail-order to patients with chronic conditions. By the end of 2000, CVS's specialty pharmacy business consisted of mail-order operations and 46 CVS ProCare pharmacies located in 17 states and the District of Columbia. Overall, CVS saw its revenues surpass the $20 billion mark for the first time in 2000, while net income reached a record $746 million."
International Directory of Company Histories

By 2001 CVS' specialty pharmacy ProCare was the "largest integrated retail/mail provider of specialty pharmacy services" in the United States.[8]:10 It was consolidated with their pharmacy benefit management company, PharmaCare in 2002. In their 2001 annual report CVS anticipated that the "$16 billion specialty pharmacy market" would grow at "an even faster rate than traditional pharmacy due in large part to the robust pipeline of biotechnology drugs."[8] By 2014 CVS Caremark, Express Scripts and Walgreens represented more than 50% of the specialty drug market in the United States.[9]:4

Strategic Business Units

Name

CVS began as Melville Corporation,[11][12] formerly based in Rye, New York.

CVS

The CVS name once stood for Consumer Value Stores; though Thomas Ryan, CVS Health's former CEO, has said he now considers it to stand for "Convenience, Value and Service".[13]

Caremark

Caremark was established by James M. Sweeney in 1979, as Home Health Care of America (HHCA), incorporated in Delaware, with corporate headquarters in Irvine, California. The first office was opened in Beachwood, Ohio, with four employees, in conjunction with Ezra Steiger, of the Cleveland Clinic Foundation. Steiger's Hyperalimentation Team worked closely to provide supplies at home for their parenteral therapy patients. Satellite offices were subsequently opened in Atlanta, Philadelphia, Houston, Chicago, and Irvine. HHCA changed its name to Caremark in 1985. In 1987, Caremark was acquired by Baxter International. In 1991 when Caremark was Baxter International's home infusion subsidiary, Caremark was accused by the United States government of "paying doctors to steer patients to its intravenous drug service."[14] Caremark was fined $160 million for the "four-year-long federal mail-fraud and kickback" scheme in which the "home-infusion business unit made weekly payments to scores of doctors that averaged about $75 per patient for referring those patients to its services. Some doctors earned as much as $80,000 a year from the kickbacks, according to government documents."[14] In 1992, Baxter spun off Caremark as a public company. Caremark sold its home infusion service and successfully branched out to four units, "a physician practice management unit, a prescription benefits management unit, a disease state management service aimed at treating high-cost, chronic diseases and an international division."[14]

In 1996, Caremark merged with Birmingham, Alabama, based MedPartners/Mullikin, Inc., with the combined company being called MedPartners, Inc. In 1998, MedPartners changed its name to Caremark Rx.[15]

Health Care Rebranding: CVS Health

On September 3, 2014, it was announced that CVS as of midnight on Tuesday Sept 2, 2014 will no longer sell tobacco at all of its 7,700 locations nationwide, which is a month earlier than previously planned. The company also announced that it would change its corporate name to CVS Health, in order to reflect "its broader health care commitment", and also a desire to change the future health of Americans, although all retail stores will continue to be called "CVS/Pharmacy".[16][17][18]

Acquisitions and growth

Since 1990, CVS has been rapidly growing in order to become a national drug store chain.

CVS had previously operated stores in southern California and completely withdrew from the market in 1993. CVS sold virtually all the locations to American Drug Stores, the drug store division of American Stores Company. American Stores operated its drug stores in southern California as Sav-on Drugs. Ironically, many of the stores in Southern California that CVS acquired were stores that CVS had formerly owned. At the time CVS bought the stores back, Sav-on operated them as Sav-on Express stores. The Express name was used by Sav-on to help customers identify those stores that did not carry all lines of merchandise as compared to the larger traditional Sav-on Drugs location, hence the name Sav-on Express. As a result of the acquisition, the chain now operates over 6,200 stores in 43 states and the District of Columbia.[27]

Community involvement

Private label

CVS has an extensive assortment of various private labels and proprietary brands. In addition to CVS Brand, CVS also carries exclusive store brands under the names of Just the Basics, Essence of Beauty, Gold Emblem, Absolutely Divine, Blade, Earth Essentials, Caliber, and Life Fitness. CVS also holds exclusive contracts to sell proprietary brands such as Nuprin, Christophe, PreVentin-AT, 24/7, Skin Effects, and the European brand Lumene. A new exclusive Playskool line of baby care is also in CVS stores. CVS was also first to sell single-use digital cameras and camcorders from Pure Digital. The acquisition of the SavOn/Osco stores from the Albertson's chain provided CVS with its first opportunity for private label spirits. At a meeting for acquisition trainers, Larry Merlo reported Tom Ryan's enthusiasm, quoting, "I am not signing my name on a bottle of vodka!"[38]

Controversies

On August 22, 2001, CVS Corp was sued for purchasing Trio Drugs' records which should be kept confidential.[39]

Elensys

In 1998, the Washington Post reported that CVS Corporation appeared to be sharing prescription drug information with the Woburn, Massachusetts, based marketing company, Elensys. According to the Post, Elensys received information on specific prescription drugs that individual CVS customers had purchased and used this information to send targeted direct mailings urging customers to renew prescriptions and promoting other products in which they might be interested. CVS and Elensys argued that there were no privacy issues because Elensys was acting solely as a contractor to CVS, and because the purpose of the mailings was to educate consumers. CVS claimed that it never shared customers' medical histories with Elensys (despite the Washington Post's indirect evidence that they had). George D. Lundberg, editor of the Journal of the American Medical Association, called the practice "a gross invasion" of privacy. Following a firestorm of criticism and complaints by consumers, CVS discontinued the relationship with Elensys, and moved the practice in-house.

Boston prescriptions

During 2005, a series of prescription mistakes came to light in some of CVS Corporation's Boston-area stores. An investigation confirmed 62 errors or quality problems going back to 2002. In February 2006, the state Board of Pharmacy announced that the non-profit Institute for Safe Medication Practices (ISMP) would monitor all Massachusetts stores for the next two years.[40]

Health and Medicare fraud

In the late 1980s and early 1990s Caremark RX was involved in a number of health fraud and Medicare fraud scandals.[41][42] The combined price to settle this dispute with the U.S. Government cost the company over $250,000,000.[43]

Pharmaceutical kickbacks

In 2005, Caremark Rx paid $137.5 million to settle federal lawsuits filed by whistle-blowers that accused a company it acquired in 2003 of improper dealings with pharmaceutical manufacturers.

The lawsuits said that the acquired company, AdvancePCS, accepted kickbacks from drug makers to promote their products over those of rivals under contracts with government programs including the Federal Employees Health Benefit Program, the Mail Handlers Health Benefit Program and Medicare health maintenance plans.

There was no admission of wrongdoing by Caremark or AdvancePCS.

CVS Caremark Corp. has changed their practices. The formulary revision process considers manufacturer rebates, payments from drug manufacturers for low placement on PBM formularies, along with average wholesale price (AWP), drug availability, and bulk discounts when choosing at which co-pay a brand name drug should be placed.[44]

Deceptive business practices

In February 2008, CVS settled a large civil lawsuit for deceptive business practices. The Kaiser Family Foundation reported:[45]

CVS has agreed to a $38.5 million settlement in a multi-state civil deceptive-practices lawsuit against pharmacy benefit manager Caremark filed by 28 attorneys general, the Chicago Tribune reports.[46] The attorneys general, led by Lisa Madigan (D) of Illinois and Douglas Ganslar (D) of Maryland, allege that Caremark "engaged in deceptive business practices" by informing physicians that patients or health plans could save money if patients were switched to certain brand-name prescription drugs (Miller, Chicago Tribune, 2/14).[46]
However, the switch often saved patients and health plans only small amounts or increased their costs, while increasing Caremark's profits, Connecticut Attorney General Richard Blumenthal (D) said (Levick, Hartford Courant, 2/15).[47] Pennsylvania Attorney General Tom Corbett (R) said the PBM[48] kept discounts and rebates that should have been passed on to employers and patients (Levy, AP/San Francisco Chronicle, 2/14).[49] In addition, Caremark did not "adequately inform doctors" of the full financial effect of the switch and did not disclose that the switch would increase Caremark's profits, the lawsuit alleges (Chicago Tribune, 2/14).[46]
...The settlement prohibits CVS from requesting prescription drug switches in certain cases, such as when the cost to the patient would be higher with the new prescription drug; when the original prescription drug's patent will expire within six months; and when patients were switched from a similar prescription drug within the previous two years (Hartford Courant, 2/15).[47] Patients also have the ability to decline a switch from the prescribed treatment to the prescription offered by the pharmacy under the settlement, Madigan said (Bloomberg News/Philadelphia Inquirer, 2/15).[50]

Rhode Island Senate corruption case

In 2008, two former CVS executives, John R. "Jack" Kramer and Carlos Ortiz, were charged with 20 counts of mail fraud, bribery and conspiracy in relation to Operation Dollar Bill, a probe of corruption in the Rhode Island General Assembly. Kramer and Ortiz hired former State Senator John Celona, who currently is serving 2½ years on corruption charges involving CVS and other companies, as a media consultant for $12,000 a year. Celona was known for walking out on a pharmacy choice vote in the state senate while on the CVS payroll. Despite originally claiming CVS never bought any favors in his own trial, he testified against Kramer and Ortiz as the prosecution's star witness. On May 31, 2008, Kramer and Ortiz were acquitted on all counts. One juror went on the record as saying “My perception living in Rhode Island all my life is, 'Yeah, this probably did go on', but I didn't see any proof beyond a reasonable doubt that CVS did this.”[51]

Business practices under investigation

On May 4, 2010, CVS Caremark Corp. announced that its business practices were being investigated by a group of 24 states, along with the District of Columbia and Los Angeles County. At issue is the post-merger relationship between CVS and Caremark. In addition, the company had earlier acknowledged in a filing with the Securities and Exchange Commission (SEC) that it had received a subpoena from the Office of Inspector General of the United States Department of Health and Human Services, requiring the company to provide information regarding the incentives the company provides to customers who transfer their prescriptions to CVS, including gift cards, goods and other incentives.[52]

FTC charges

On February 18, 2009, CVS Caremark agreed to settle Federal Trade Commission charges that it failed to take reasonable and appropriate security measures to protect the sensitive financial and medical information of its customers and employees, in violation of federal law. In a separate but related agreement, the company’s pharmacy chain also has agreed to pay $2.25 million to resolve Department of Health and Human Services allegations that it violated the Health Insurance Portability and Accountability Act (HIPAA).[53]

FTC deceptive pricing charges

On January 12, 2012, CVS Caremark paid $5 million to settle Federal Trade Commission charges that it misrepresented the prices of certain Medicare Part D prescription drugs – including drugs used to treat breast cancer symptoms and epilepsy – at CVS and Walgreens pharmacies.[54]

DEA investigation into Oxycodone diversion

See also: Drug diversion

According to the U.S. Justice Department, in 2011 CVS pharmacies in Sanford, Florida, ordered enough painkillers to supply a population eight times its size. Sanford has a population of 53,000 but the supply would support 400,000.[55] According to the Drug Enforcement Administration, in 2010 a single CVS pharmacy in Sanford ordered 1.8 million Oxycodone pills, an average of 137,994 pills a month. Other pharmacy customers in Florida averaged 5,364 oxycodone pills a month. DEA investigators serving a warrant to a CVS pharmacy in Sanford on October 18, 2011, noted that "approximately every third car that came through the drive-thru lane had prescriptions for oxycodone or hydrocodone". According to the DEA, a pharmacist at that location stated to investigators that "her customers often requested certain brands of oxycodone using street slang", an indicator that the drugs were being diverted and not used for legitimate pain management. In response, CVS in a statement issued February 17 in response to opioid trafficking questions from USA Today said the company is committed to working with the DEA and had taken "significant actions to ensure appropriate dispensing of painkillers in Florida".[56]

Restatements

On November 15, 1999, CVS announced a restatement of its financial results for 1997 and 1998 following a Securities and Exchange Commission review of acquisition-related charges.[57]

On February 25, 2005, CVS said it was reducing its previously announced fourth-quarter earnings by $40.5 million, to reflect the way it accounted for leased properties in its results.[58]

Tobacco product sales discontinued

On February 5, 2014 CVS announced that the company would discontinue the sale of all tobacco and cigarette products from their stores by October 1, 2014. In a statement explaining the change, CVS President & CEO Larry J. Merlo said, "We came to the decision that cigarettes and providing health care just don't go together in the same setting."[59]

See also

References

  1. 1 2 3 4 5 6 "2015 annual results". CVS Health Corp.
  2. "CVS Caremark Announces Corporate Name Change to CVS Health to Reflect Broader Health Care Commitment - CVS Health". CVS Health. Retrieved 15 June 2015.
  3. 1 2 "CVS/pharmacy". CVS Health. Retrieved 15 June 2015.
  4. "CVS Health". Retrieved 2015-08-12.
  5. "CVS Caremark". Fortune Global 500. 2013.
  6. CVS Caremark. Fortune 500. Retrieved on 2014-08-07.
  7. CVS Corporation History. St. James Press. International Directory of Company Histories 45. 2002. Retrieved 3 November 2015.
  8. 1 2 "CVS Annual Report" (PDF). CVS. 2001. Retrieved 17 October 2015.
  9. "Overview of the Specialty Drug Trend" (PDF). IMS Health. 2014. p. 11. Retrieved 5 October 2015.
  10. "CVS/minuteclinic". CVS Health. Retrieved 15 June 2015.
  11. "CVS Caremark, Form 8-K, Current Report, Filing Date Jun 7, 1996". secdatabase.com. Retrieved Mar 29, 2013.
  12. 1 2 "CVS Caremark, Form 8-K, Current Report, Filing Date Dec 6, 1996". secdatabase.com. Retrieved Mar 29, 2013.
  13. Berlinski, Peter (January–February 2006). "Ryan Preaches PL to CVS Team". Private Label Magazine. Retrieved 2008-03-03.
  14. 1 2 3 Yates, Ronald E. (19 June 1995). "Caremark Wounds Not Deep Penalty Could Have Been More Damaging". Chicago Tribune. Retrieved 17 October 2015.
  15. "Hoover's Profile: Caremark Pharmacy Services". Answers.com. Retrieved 2008-03-03.
  16. Japsen, Bruce. "CVS Stops Tobacco Sales Today, Changes Name To Reflect New Era". Forbes. Retrieved 3 September 2014.
  17. O'Donnel, Jayne; Ungar, Laura. "CVS stops selling tobacco, offers quit-smoking programs". USA Today. Retrieved 3 September 2014.
  18. "CVS Stops Tobacco Sales Sooner Than Planned, Changes Name". NBC News. Retrieved 3 September 2014.
  19. "CVS History". CVS Caremark. Archived from the original on 2008-02-13. Retrieved 2008-03-03.
  20. "CVS Caremark, Form 10-K, Annual Report, Filing Date Mar 29, 1995". secdatabase.com. Retrieved Mar 29, 2013.
  21. "CVS Caremark, Form 8-K, Current Report, Filing Date May 30, 1997". secdatabase.com. Retrieved Mar 29, 2013.
  22. "CVS Caremark, Form 8-K, Current Report, Filing Date Apr 3, 1998". secdatabase.com. Retrieved Mar 29, 2013.
  23. "CVS Caremark, Form 10-Q, Quarterly Report, Filing Date Nov 14, 2000". secdatabase.com. Retrieved Mar 29, 2013.
  24. "CVS Caremark, Form 8-K, Current Report, Filing Date Apr 6, 2004" (PDF). secdatabase.com. Retrieved Mar 29, 2013.
  25. "CVS Caremark, Form 8-K, Current Report, Filing Date Jun 30, 2006" (PDF). secdatabase.com. Retrieved Mar 29, 2013.
  26. "CVS Caremark, Form 8-K/A, Filing Date Aug 8, 2006". secdatabase.com. Retrieved Mar 29, 2013.
  27. "CVS to Postpone Shareholder Meeting to Vote on Caremark Merger" (Press release). CVS Caremark. Retrieved 2008-03-03.
  28. Dorfman, Brad (2007-11-15). "CVS focused on integrating mergers". Reuters. Retrieved 2008-02-25.
  29. "CVS Caremark, Form 8-K, Current Report, Filing Date Mar 23, 2007" (PDF). secdatabase.com. Retrieved Mar 29, 2013.
  30. "CVS Caremark, Form 8-K, Current Report, Filing Date Mar 23, 2007". secdatabase.com. Retrieved Mar 29, 2013.
  31. "CVS Caremark, Form 8-K, Current Report, Filing Date Nov 7, 2007". secdatabase.com. Retrieved Mar 29, 2013.
  32. "CVS Caremark, Form 8-K, Current Report, Filing Date Oct 20, 2008". secdatabase.com. Retrieved Mar 29, 2013.
  33. Jessica Wohl (2008-11-03). "CVS to open Beauty 360 store; dozens more in '09". Reuters. Retrieved 2010-06-07.
  34. Randy Hofbauer (2014-07-14). "CVS to acquire Navarro Discount Pharmacy". Store Brands magazine, Stagnito Business Information. Retrieved 2014-07-15.
  35. Dan Gould (2014-06-15). "CVS Health and Target Sign Agreement for CVS Health to Acquire, Rebrand and Operate Target’s Pharmacies and Clinics". CVS Health. Retrieved 2015-06-15.
  36. "CVS Caremark Charitable Trust". CVS Caremark. Archived from the original on 2008-02-13. Retrieved 2008-03-03.
  37. "CVS Caremark Charity Classic". CVS Caremark. Retrieved 2008-03-03.
  38. Larry Merlo, 06/22/2006, Corporate Headquarters, Woonsocket, RI
  39. "CE: Recent legal cases of 2001: A heads-up for pharmacists".
  40. Rowland, Christopher (2006-02-10). "CVS faces pharmacy reviews". Boston Globe. Retrieved 2008-02-25.
  41. "Caremark to Pay $161 Million in Fraud and Kickback Cases" (Press release). U.S. Department of Justice. Retrieved 2008-02-25.
  42. "Report: Caremark, DOJ nearing settlement". Nashville Business Journal. 2005-05-27. Retrieved 2008-02-25.
  43. In Re Caremark Int'l, Inc., Derivative Litigation, A.2d 959 (Delaware Chancery Court 1996).
  44. "Pharmacy Benefit Managers". Prescription Policy Choices. Retrieved 2 May 2011.
  45. "CVS Caremark Agrees To Pay $38.5M To Settle Allegations That It Did Not Pass on Rebates, Discounts to Patients, Employers". Kaiser Daily Health Policy Report. Kaiser Family Foundation. 2008-02-15. Retrieved 2008-02-25.
  46. 1 2 3 Miller, James P. (2008-02-14). "CVS Caremark settles deceptive-practices complaint for $38.5 million". Chicago Tribune. Retrieved 2013-04-29.
  47. 1 2 Levick, Diane (2008-02-15). "Caremark Settles States' Probe". Hartford Courant. Retrieved 2008-02-25.
  48. Pharmacy Benefit Manager
  49. Levy, Marc (2008-02-14). "Caremark to pay $38M to settle drug-switching complaint". AP/San Francisco Chronicle. Archived from the original on 2008-06-11. Retrieved 2008-02-25.
  50. Harris, Andrew (2008-02-15). "CVS to pay millions to settle drug-cost case". Bloomberg News/Philadelphia Inquirer. Retrieved 2008-02-25.
  51. "Kramer, Ortiz innocent". Providence Journal. May 31, 2008.
  52. "CVS Says Its Business Practices Probed by 24 States (Update1)". BusinessWeek. 2010-05-04. Retrieved 2010-06-07.
  53. "CVS Caremark Settles FTC Charges". Federal Trade Commission. 2009-02-18. Retrieved 2012-01-15.
  54. "CVS Caremark Corporation Settles FTC Deceptive Pricing Charges". Federal Trade Commission. 2012-01-12. Retrieved 2012-01-15.
  55. Schoenberg, Tom (2012-02-29). "Cardinal Health Blocked From Shipping Painkiller in Florida". Bloomberg.
  56. "Most Popular E-mail Newsletter". USA Today. 2012-02-27.
  57. "CVS Will Restate Results After SEC Prompts Revision Of Charges".
  58. "CVS to restate 4Q on accounting change".
  59. "CVS Plans to End Sales of Tobacco Products by Oct. 1".

External links

This article is issued from Wikipedia - version of the Thursday, February 11, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.